CLINICAL, LABORATORY AND PROGNOSTIC FEATURES OF MASKED ARTERIAL HYPERTENSION IN MIDLIFE WORKING WOMEN

Objective. Late detection and diagnostics of masked hypertension (MHTN) triggering cardiovascular continuum is still one of the key issues in healthcare system. Design and methods. We examined 309 midlife women (31–57 years old) working in institutions without specified factors of occupational hazards. We excluded patients with verified pathology, taking oral contraception or hormonotherapy. MHTN was verified based on the following criteria: combination of normal office blood pressure (BP) (≤ 140/90 mm Hg), positive breathhold test and elevated BP according to the results of 24-hour BP monitoring. Results and conclusions. MHTN was detected in 8,7 %. We defined clinical features of MHTN in examined population: absence of complaints and anamnesis of cardiovascular diseases, elevated mean haemodynamic pressure, and increased body mass index. Analysis of clinical and laboratory results showed no difference between mean parameters of lipid profile in the examined population, despite higher dyslipidemia rate among patients with hypertension and MHTN as compared to patients without hypertension (p < 0,05). The tendency towards elevation of fasting blood glucose and decreasing of glomerular filtration rate in patients with MHTN was not significantly different. Ten-year risk of fatal cardiovascular events (assessed by survival model based on Weibull function) in midlife working women with MHTN was comparable with women with manifest hypertension.

1. Чазова И. Е., Жернакова Ю. В., Ощепкова Е. В., Шальнова С. А., Яровая Е. Б., Конради А. О. и др. Распространенность факторов риска развития сердечно-сосудистых заболеваний в российской популяции больных артериальной гипертонией. Кардиология. 2014;54(10):4–12. [Chazova IE, Zhernakova JuV, Oshhepkova EV, Yarovaya EB, Konradi AO et al. Prevalence of cardiovascular diseases risk factors in Russian population of patients with arterial hypertension. Kardiologiia = Cardiology. 2014;54 (10):4–12. In Russian].

2. Стаховская Л. В., Клочихина О. А., Богатырева М. Д., Коваленко В. В. Эпидемиология инсульта в России по результатам территориально-популяционного регистра (2009–2010). Журнал неврологии и психиатрии. 2013;5:4–10. [Stahovskaja LV, Klochihina OA, Bogatyreva MD, Kovalenko VV. Epidemiology of cerebral accidents in Russia according to the results of communitybased populational registry (2009–2010). Zhurnal Nevrologii i Psihiatrii = Journal of Neurology and Psychiatry. 2013;5:4–10. In Russian].

3. Panagiotakos DB, Fitzgerald AP, Pitsavos C, Pipilis A, Graham I, Stefanadis C. Statistical modelling of 10-year fatal cardiovascular disease risk in Greece: the Hellenic SCORE (a calibration of the ESC SCORE project). Hellenic J Cardiol. 2007;48(2):55–63.

4. Ralph B, D’Agostino Sr, Pencina MJ, Coady S. Cardiovascular disease risk assessment: insights from Framingham. Glob Heart. 2013;8(1):11–23.

5. Muntner P, Lewis CE, Diaz K, Carson AP, Kim Y, Calhoun D. Racial differences in abnormal ambulatory blood pressure monitoring measures: results from the coronary artery risk development in young adults (CARDIA) study. Am J Hypertens. 2014. doi: 10.1093/ajh/hpu193.

6. Grassi G, Mancia G. The PAMELA study — results and perspectives. E-journal of Cardiology Practice. E-journal. 2011;10(5):13 Оct. [Internet]. Avaiabe from: http://www.escardio. org/ communities/councils/ccp/ejournal/volume10/Pages/ PAMELA-epidemiology-study-providing-dynamic-informationon-hypertension. aspx#.VPSS3uhwuEk (access data 03.03.2015).

7. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J et al. Prognosis of «masked» hypertension and «whitecoat» hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46(3):508–515.

8. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25(11):2193– 2198.

9. Ogedegbe G, Agyemang C, Ravenell JE. Masked hypertension: evidence of the need to treat. Curr Hypertens Rep. 2010;12(5):349–355.

10. Writing Group for Women’s Health Initiative Investigator s. J Am Med Assoc. 2002;288(3):321–333.

11. Чазова И. Е., Фомин В. В., Разуваева М. А., Вигдорчик А. В. Эпидемическая характеристика резистентной и неконтролируемой артериальной гипертонии РЕГАТА-ПРИМА. Системные гипертензии. 2010;3:34–41. [Chazova IE, Fomin VV, Razuvaeva MA, Vigdorchik AV. Epidemical characteristic of resistant and uncontrolled arterial hypertension REGATAPRIMA. Sistemniye Gypertenzii = Systemic Hypertensions. 2010;3:34–41. In Russian].

12. Alessi A, Brandao АА, Paiva АМ, Rocha Nogueira AD, Feitosa A, Campos Gonzaga CD et al. I Brazilian position paper on prehypertension, white coat hypertension and masked hypertension: diagnosis and management. Arq Bras Cardiology. 2014;102(2):110–118.

13. Lyamina NP, Smith ML, Lyamina SV, Manukhina EB, Senchikhin VN, Pacchia CF et al. Pressor response to 30-s breathhold: a predictor of masked hypertension. J Blood Press. 2012;21(6):372–376. doi: 10.3109/08037051.2012.694213. Epub 2012 Jun 25.

14. Лямина Н. П., Лямина С. В., Сенчихин В. Н., Додина К. А. Функциональная проба по выявлению латентной артериальной гипертонии у лиц молодого возраста. Кардиология. 2011;51(4):28–30. [Lyamina NP, Lyamina SV, Senchikhin VN, Dodina KA. Functional probe of latent arterial hypertension detection in young patients. Kardiologiia = Cardiology. 2011;51 (4):28–30. In Russian].

15. Рогоза А. Н., Агальцов М. В., Сергеева М. В. Суточное мониторирование артериального давления: варианты врачебных заключений и комментарии. Нижний Новгород. Издательство ДЕКОМ. 2005:12–17. [Rogoza AN, Agaltsov MV, Sergeeva MV. Daily blood pressure monitoring: variants of medical reports and comments. Nizhnij Novgorod. Izdatel’stvo DEKOM=DEKOM Edition. 2005:12–17. In Russian].